Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 2/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | ST6GAL1 | P15907 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.37 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.37 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7780247 | 1.00 | L3MBTL1 (0.54) | L3MBTL1ALDH1A1CYP2C19EPHX1DPP4 | |
| SCHEMBL6535845 | 0.85 | CYP2C19 (0.50) | L3MBTL1CYP2C19EPHX1CYP19A1GRIK1 | |
| SCHEMBL7779241 | 0.85 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1CYP2C19EPHX1CYP19A1 | |
| SCHEMBL7779238 | 0.85 | L3MBTL1 (0.43) | L3MBTL1ALDH1A1CYP2C19EPHX1CYP19A1 | |
| SCHEMBL1845736 | 0.84 | GRIN1 (0.46) | L3MBTL1EPHX1DPP4CYP19A1GRIK1 | |
| SCHEMBL1845735 | 0.84 | GRIN1 (0.46) | L3MBTL1EPHX1DPP4CYP19A1GRIK1 | |
| SCHEMBL16086118 | 0.83 | EPHX1 (0.42) | L3MBTL1CYP2C19EPHX1CYP19A1GRIK1 | |
| SCHEMBL15359992 | 0.83 | EPHX1 (0.42) | L3MBTL1CYP2C19EPHX1CYP19A1GRIK1 | |
| SCHEMBL5868653 | 0.82 | L3MBTL1 (0.38) | L3MBTL1DPP4ST6GAL1TYR | |
| SCHEMBL18459936 | 0.81 | EPHX1 (0.41) | L3MBTL1CYP2C19EPHX1CYP19A1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113788877-A | Novel insect kinin analogs and application thereof in aphid control | 中国农业大学 | 2021-12-14 | — | — | CN | claimed |
| CN-113788877-B | Novel insect kinin analogues and application thereof in aphid control | 中国农业大学 | 2023-11-21 | — | — | CN | disclosed |
| CN-114478324-B | Active compound and application thereof in side chain carboxyl compound protection | 上海嘉莱多生物技术有限责任公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-114478324-A | Active compound and application thereof in side chain carboxyl compound protection | 上海嘉莱多生物技术有限责任公司 | 2022-05-13 | — | — | CN | disclosed |
| CN-113788877-A | Novel insect kinin analogs and application thereof in aphid control | 中国农业大学 | 2021-12-14 | — | — | CN | disclosed |
| US-10550153-B2 | Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof | TOKYO UNIVERSITY OF PHARMACY & LIFE SCIENCES (JP) | 2020-02-04 | — | — | US | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10550153-B2 | Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof | NMUR2, NMUR1, NTSR2 | L3MBTL1 3830/4885ALDH1A1 2714/4885CYP2C19 2084/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.